A drug test detects traces of specific substances, or their byproducts, in a biological sample like urine, saliva, blood, or hair. It doesn’t measure impairment or tell anyone whether you’re currently under the influence. Instead, it identifies chemical evidence that a substance was in your body within a certain window of time, ranging from hours to months depending on the test type.
What a Drug Test Screens For
Federal workplace drug testing follows a standard panel set by the Department of Health and Human Services. The current panel covers marijuana, cocaine, opioids (including codeine, morphine, hydrocodone, oxycodone, and fentanyl), amphetamines (including methamphetamine and MDMA), and PCP. Private employers can test for a broader or narrower list depending on state law and company policy, sometimes adding benzodiazepines, barbiturates, or other substances.
Each substance on the panel has a specific concentration threshold. Your sample isn’t simply “positive” or “negative” for a drug. It’s positive only if the concentration exceeds a set cutoff. For example, the federal urine screening cutoff for marijuana metabolites is 50 nanograms per milliliter, while cocaine metabolites must reach 150 ng/mL and fentanyl just 1 ng/mL. These thresholds exist to reduce the chance that incidental or trace exposure triggers a positive result.
How the Two-Step Testing Process Works
Drug testing almost always happens in two stages: a fast initial screen, followed by a more precise confirmatory test if the screen flags something.
The initial screen uses a technology called immunoassay. In simple terms, your sample is mixed with antibodies designed to latch onto a specific drug or its byproduct. If the drug is present above the cutoff level, it triggers a measurable chemical reaction, either a color change on a test strip or an enzyme activation that a machine can read. Rapid point-of-care tests (the kind that look like a dipstick or test cassette) work on a similar principle: colored microbeads flow across a strip, and the pattern of visible bands tells the technician whether the result is positive or negative. These screens are fast but not perfectly specific, which is why a positive result always needs confirmation.
The confirmatory step uses a more sophisticated approach. The lab separates your sample into its individual chemical components using a technique called chromatography, then feeds those components through a mass spectrometer, which identifies each molecule by its unique physical signature. This process can distinguish between structurally similar compounds that an immunoassay might confuse, and the confirmatory cutoffs are often lower. For marijuana in urine, the confirmatory cutoff drops from 50 ng/mL to 15 ng/mL. For cocaine, it drops from 150 to 100 ng/mL.
Sample Types and Detection Windows
The type of sample collected determines how far back the test can “see.” Each has trade-offs between convenience, detection range, and what it actually reveals.
- Urine is the most common specimen for workplace testing. A single dose of most drugs is detectable for roughly 1.5 to 4 days. Chronic users may test positive for about a week after their last use, and heavy, long-term marijuana or cocaine users can test positive even longer.
- Oral fluid (saliva) captures a much shorter window, typically 5 to 48 hours. It’s harder to tamper with because the collection happens under direct observation, and federal guidelines now authorize it as an alternative to urine.
- Blood offers the shortest detection window. Most substances are measurable for only one to two days. Blood tests are less common in workplace settings but sometimes used in emergency medical situations or accident investigations.
- Hair provides the longest lookback period. Head hair grows at roughly half an inch per month, so a standard 1.5-inch sample covers approximately 90 days of drug exposure. Hair testing is useful for identifying patterns of use over time but won’t catch something consumed in the last few days, since it takes about a week for drug deposits to grow past the scalp.
What Happens During Collection
For a urine test, you’ll typically go to a designated collection site, present a photo ID, and provide your sample in a private restroom. The collector checks the specimen’s temperature immediately. It must fall between 90°F and 100°F; a sample outside that range raises suspicion that it may have been swapped or tampered with. The collector then seals the sample in a tamper-evident container and documents every person who handles it, creating what’s called a chain of custody. This paper trail ensures the sample can be traced from collection to final result, which matters if the results are challenged legally.
Oral fluid collection is simpler. A swab or absorbent pad is placed between your cheek and gum for a few minutes. Hair collection involves cutting a small sample, about the diameter of a pencil, as close to the scalp as possible, usually from the back of the head.
Why False Positives Happen
The initial immunoassay screen can sometimes react to substances that are chemically similar to the target drug. This is one of the most important things to understand about drug testing: a screening positive is not a confirmed positive.
A wide range of common medications have been documented to trigger false-positive results. Ibuprofen and naproxen have caused false positives for marijuana or barbiturates. Certain antihistamines like diphenhydramine (the active ingredient in Benadryl) and dextromethorphan (a common cough suppressant) have triggered false positives for PCP or opioids. The antidepressants bupropion, sertraline, trazodone, and venlafaxine have all been linked to false-positive results for amphetamines, which is the most commonly reported type of false positive overall. Even a nonprescription nasal decongestant inhaler can flag for methamphetamine on an initial screen.
This is exactly why the two-step process exists. The confirmatory test using chromatography and mass spectrometry can tell the difference between, say, an antidepressant and actual methamphetamine. If you’re taking a prescription or over-the-counter medication that might cross-react, you’ll typically have the opportunity to disclose it to a medical review officer, the physician who evaluates confirmed positive results before they’re reported to your employer.
How Results Are Reported
If the initial screen comes back negative, the process stops and a negative result is reported. If the screen is positive, the same sample goes through confirmatory testing. Only after the confirmatory test also comes back positive does a medical review officer get involved. That officer contacts you to ask about legitimate prescriptions or medical explanations before finalizing the result.
Results are reported as negative, positive, dilute (meaning the urine was too watery to produce a reliable reading), or substituted/invalid (meaning the specimen didn’t appear to be genuine human urine). A dilute result often means you’ll be asked to test again. The entire process, from collection to final reported result, typically takes a few business days for a negative screen and up to a week or more if confirmatory testing and medical review are needed.